Neoadjuvant dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer
1. All neoadjuvant dostarlimab patients had a clinical complete response and no patients needed any additional treatments at the study ...
Tag: programmed cell death protein 1 (PD-1)
Atezolizumab may increase overall survival in patients with metastatic non-small-cell lung cancer
1. Atezolizumab significantly increased overall survival compared to platinum-based combination chemotherapy in participants with untreated metastatic non-small-cell lung cancer (NSCLC) ...
Quick Take: Pembrolizumab Versus Chemotherapy for Previously Untreated, PD-L1-Expressing, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (KEYNOTE-042)
Pembrolizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1). Previous studies have shown that pembrolizumab is effective ...
2 Minute Medicine Rewind April 8, 2019
Association of Racial Disparities With Access to Kidney Transplant After the Implementation of the New Kidney Allocation System There are ...